All Brands Owned by bioMerieux SA

What does bioMerieux own?

bioMerieux owns diagnostic product families including BIOFIRE, SPOTFIRE, VITEK, and VIDAS, plus subsidiaries such as BioFire Diagnostics in the United States. Its business is instruments, reagents, and software rather than consumer brands.

Is bioMerieux publicly traded?

Yes. bioMerieux trades on Euronext Paris under ticker BIM and is part of the SBF 120 index. The Merieux family retains majority control through Institut Merieux.

Who founded bioMerieux?

Alain Merieux founded the modern company in 1963, building on the family medical enterprise started by his father Marcel Merieux in 1897. The family has controlled the business for four generations.

Where is bioMerieux headquartered?

The company is headquartered in Marcy l'Etoile, a suburb of Lyon in the Auvergne-Rhone-Alpes region of France. Its largest manufacturing and R&D site outside France is in Salt Lake City, Utah.

How many brands does bioMerieux own?

Its portfolio centers on a small set of product families rather than many brands: BIOFIRE, SPOTFIRE, VITEK, VIDAS, and the BioFire Diagnostics subsidiary that makes them. It owns roughly a dozen significant product lines.

Who owns bioMerieux?

The Merieux family holds a majority stake through Institut Merieux and Compagnie Merieux Alliance. The remaining shares trade publicly on Euronext Paris and are held by institutional and retail investors.

What is bioMerieux's revenue?

The company reported sales of 4,070 million euros for fiscal year 2025, up 6.2 percent organically, with contributive operating income before non-recurring items of 728 million euros.